Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial. The Japanese Cooperative Study Group of PBSCT.

Source:http://linkedlifedata.com/resource/pubmed/id/9834207

Blood 1998 Dec 1 92 11 4040-6

Download in:

View as

General Info

PMID
9834207